Olefins provide a most efficient entry to organic compounds with diverse and controllable functionality. The goals of this program are to discover and improve a variety of methods for selective olefin oxidation, including osmium-catalyzed aminohydroxylation and dihydroxylation, rhenium-catalyzed epoxidation, bromine-catalyzed aziridination, and ruthenium tetroxide catalyzed oxidation reactions. Emphasis is placed on catalytic aminohydroxylation in both racemic and enantioselective modes, as this problem presents both the greatest challenges and the great potential rewards for synthetic utility. Preliminary results have provided exciting mechanistic insights in this area. Additionally, single-atom transfers mediated by osmium and other d(0)-metals, based on the exploration of the """"""""spectator-oxo"""""""" principle, will be studied. This heretofore little explored reactivity should greatly expand the scope of the transition metal-mediated oxidation processes. The products of olefin oxidation of greatest importance as synthetic intermediates are high-energy compounds that engage in rapid and selective subsequent transformations. Chief among these are epoxides, aziridines, cyclic sulfates, and episulfonium ions. New methods for the synthesis and manipulation of these intermediates are discussed. The ultimate goal is the development and exploitation of an expanded set of highly reliable reactions for the preparation of organic compounds of use to the exciting disciplines of diversity chemistry and drug discovery.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM028384-27S2
Application #
8048310
Study Section
Medicinal Chemistry Study Section (MCHA)
Program Officer
Hagan, Ann A
Project Start
1981-01-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
27
Fiscal Year
2010
Total Cost
$214,386
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Hein, Jason E; Tripp, Jonathan C; Krasnova, Larissa B et al. (2009) Copper(I)-catalyzed cycloaddition of organic azides and 1-iodoalkynes. Angew Chem Int Ed Engl 48:8018-21
Kalisiak, Jaroslaw; Sharpless, K Barry; Fokin, Valery V (2008) Efficient synthesis of 2-substituted-1,2,3-triazoles. Org Lett 10:3171-4
Whiting, Matthew; Fokin, Valery V (2006) Copper-catalyzed reaction cascade: direct conversion of alkynes into N-sulfonylazetidin-2-imines. Angew Chem Int Ed Engl 45:3157-61
Cassidy, Michael P; Raushel, Jessica; Fokin, Valery V (2006) Practical synthesis of amides from in situ generated copper(I) acetylides and sulfonyl azides. Angew Chem Int Ed Engl 45:3154-7
Radic, Zoran; Manetsch, Roman; Krasinski, Antoni et al. (2005) Molecular basis of interactions of cholinesterases with tight binding inhibitors. Chem Biol Interact 157-158:133-41
Krasinski, Antoni; Radic, Zoran; Manetsch, Roman et al. (2005) In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors. J Am Chem Soc 127:6686-92
Feldman, Alina K; Colasson, Benoit; Sharpless, K Barry et al. (2005) The allylic azide rearrangement: achieving selectivity. J Am Chem Soc 127:13444-5
Wu, Peng; Malkoch, Michael; Hunt, Jasmine N et al. (2005) Multivalent, bifunctional dendrimers prepared by click chemistry. Chem Commun (Camb) :5775-7
Narayan, Sridhar; Muldoon, John; Finn, M G et al. (2005) ""On water"": unique reactivity of organic compounds in aqueous suspension. Angew Chem Int Ed Engl 44:3275-9
Johnson, Steven M; Petrassi, H Michael; Palaninathan, Satheesh K et al. (2005) Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation. J Med Chem 48:1576-87

Showing the most recent 10 out of 41 publications